In contrast, reduction of SPRY2 (sprouty homolog 2) expression causes hyperactivation of PI3K/AKT signaling to drive prostate cancer cell proliferation and invasion by enhanced internalization of EGFR and sustained signaling at early endosomes in a PTEN-dependent manner [33]. The gene discussed is AKT1; the disease is prostate carcinoma.